Program Director/Principal Investigator:
(Last, first, middle)
For Non-competing Progress Reports (PHS 2590) – Submit only Active Support for Key Personnel
PHS 398/2590 OTHER SUPPORT
Provide active support for all key personnel. Other Support includes all financial resources, whether Federal, non-Federal, commercial or institutional, available in direct support of an individual's research endeavors, including but not limited to research grants, cooperative agreements, contracts, and/or institutional awards. Training awards, prizes, or gifts do not need to be included.
There is no "form page" for other support. Information on other support should be provided in the format shown below, using continuation pages as necessary. Include the principal investigator's name at the top and number consecutively with the rest of the application. The sample below is intended to provide guidance regarding the type and extent of information requested.
For instructions and information pertaining to the use of and policy for other support, see Other Support in the PHS 398 Part III, Policies, Assurances, Definitions, and Other Information.
Note effort devoted to projects must now be measured using person months. Indicate calendar, academic, and/or summer months associated with each project.
NAME OF INDIVIDUAL
Project Number (Principal Investigator)
Title of Project (or Subproject)
The major goals of this project are…
Dates of Approved/Proposed Project
Annual Direct Costs
OVERLAP (summarized for each individual)
2 R01 HL 00000-13 (Anderson) 3/1/1997 – 2/28/2002 3.60 calendar
Chloride and Sodium Transport in Airway Epithelial Cells
The major goals of this project are to define the biochemistry of chloride and sodium transport in airway epithelial cells and clone the gene(s) involved in transport.
5 R01 HL 00000-07 (Baker) 4/1/1994 – 3/31/2002 1.20 calendar
Ion Transport in Lungs
The major goal of this project is to study chloride and sodium transport in normal and diseased lungs.
R000 (Anderson) 9/1/1996 – 8/31/2002 1.20 calendar
Cystic Fibrosis Foundation $43,123
Gene Transfer of CFTR to the Airway Epithelium
The major goals of this project are to identify and isolate airway epithelium progenitor cells and express human CFTR in airway epithelial cells.
DCB 950000 (Anderson) 12/01/2002 – 11/30/2004 2.40 calendar
National Science Foundation $82,163
Liposome Membrane Composition and Function
The major goals of this project are to define biochemical properties of liposome membrane components and maximize liposome uptake into cells.
There is scientific overlap between aim 2 of NSF DCB 950000 and aim 4 of the application under consideration. If both are funded, the budgets will be adjusted appropriately in conjunction with agency staff.
5 R01 CA 00000-07 (Hernandez) 4/1/1995 – 3/31/2002 3.60 academic
Gene Therapy for Small Cell Lung Carcinoma
The major goals of this project are to use viral strategies to express the normal p53 gene in human SCLC cell lines and to study the effect on growth and invasiveness of the lines.
5 P01 CA 00000-03 (Chen) 7/1/2000 – 6/30/2002 1.80 academic
NIH/NCI $104,428 (sub only) 3.00 summer
Mutations in p53 in Progression of Small Cell Lung Carcinoma
The major goals of this subproject are to define the p53 mutations in SCLC and their contribution to tumor progression and metastasis.
BE 00000 (Hernandez) 9/1/1996 – 8/31/2002 1.80 academic
American Cancer Society $86,732
p53 Mutations in Breast Cancer
The major goals of this project are to define the spectrum of p53 mutations in human breast cancer samples and correlate the results with clinical outcome.
Potential commitment overlap for Dr. Hernandez between 5 R01 CA 00000-07 and the application under consideration. If the application under consideration is funded with Dr. Hernandez committed at 3.60 person months, Dr. Hernandez will request approval to reduce her months on the NCI grant.
Investigator Award (Bennett) 9/1/1999 – 8/31/2002 9.00 calendar
Howard Hughes Medical Institute $581,317
Gene Cloning and Targeting for Neurological Disease Genes
This award supports the PI’s program to map and clone the gene(s) implicated in the development of Alzheimer’s disease and to target expression of the cloned gene(s) to relevant cells.
PHS 398/2590 (Rev. 06/09) Page ___ Other Support Format Page